Frankfurt - Delayed Quote EUR

Siemens Healthineers AG (SHL.F)

52.36 -0.16 (-0.30%)
As of 8:01 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Bernhard Montag President, CEO & Chairman of Management Board 3.15M -- 1969
Dr. Jochen Schmitz Ph.D. CFO & Member of Management Board 1.86M -- 1966
Ms. Darleen Caron Chief Human Resources Officer, Labor Director & Member of Management Board 1.66M -- 1964
Ms. Elisabeth Staudinger-Leibrecht Member of Management Board 1.15M -- 1970
Mr. Marc Koebernick Head of Investor Relations -- -- --
Christian Klaussner Executive Vice President of Finance -- -- --
Andre Hartung Head of Imaging -- -- --
Carsten Bertram Head of Advanced Therapies -- -- --
Mr. David C. Pacitti Head of Americas -- -- 1967
Ms. Sharon J. Bracken Head of Diagnostics -- -- 1971

Siemens Healthineers AG

Siemensstr. 3
Forchheim, 91301
Germany
49 9131 84 3385 https://www.siemens-healthineers.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
71,400

Description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Corporate Governance

Siemens Healthineers AG’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 3; Board: 6; Shareholder Rights: 6; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 19, 2024
    Ex-Dividend Date

Upcoming Events

May 07, 2024
Siemens Healthineers AG Earnings Call